EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
1-Year Return
51.18%
This Quarter Return
+13.98%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5B
AUM Growth
+$534M
(+12%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
2.81%
Top 10 Holdings %
Top 10 Hldgs %
30.17%
Holding
159
New
25
Increased
53
Reduced
17
Closed
16
Top Buys
| 1 |
Annexon
ANNX
|
$52.4M |
| 2 |
Ecolab
ECL
|
$46M |
| 3 |
GTM
ZoomInfo Technologies
GTM
|
$44.9M |
| 4 |
Cintas
CTAS
|
$44.3M |
| 5 |
Sprout Social
SPT
|
$37.7M |
Top Sells
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$53.4M |
| 2 |
Lennox International
LII
|
$43.6M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$40.3M |
| 4 |
SPLK
Splunk Inc
SPLK
|
$37.4M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
$33.4M |
Sector Composition
| 1 | Healthcare | 41.81% |
| 2 | Technology | 24.56% |
| 3 | Industrials | 10.55% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Neurocrine Biosciences
NBIX
$13.7B
| $34.6M | 0.68% |
360,200
+2,400
| +0.7% | +$231K |
|
52
Datadog
DDOG
$46B
| $34.3M | 0.67% |
335,335
+6,335
| +2% | +$647K |
|
|
SPLK
53
DELISTED
Splunk Inc
SPLK
| $34.1M | 0.67% |
181,237
-198,763
| -52% | -$37.4M |
|
|
TPTX
54
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $33.5M | 0.66% |
383,000
| – | – |
|
55
Immunovant
IMVT
$2.87B
| $32.8M | 0.64% |
932,000
+306,050
| +49% | +$10.8M |
|
56
Veracyte
VCYT
$2.45B
| $30.2M | 0.59% |
930,000
| – | – |
|
57
Novanta
NOVT
$4.1B
| $29.8M | 0.58% |
282,492
+2,492
| +0.9% | +$263K |
|
|
GBT
58
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $29.5M | 0.58% |
535,000
| – | – |
|
59
Zentalis Pharmaceuticals
ZNTL
$121M
| $28.8M | 0.56% |
911,416
-3,289
| -0.4% | -$104K |
|
60
Rollins
ROL
$27.5B
| $26.3M | 0.51% |
727,500
-231,000
| -24% | -$8.35M |
|
|
61
Lennox International
LII
$19.8B
| $25.9M | 0.51% |
95,000
-160,000
| -63% | -$43.6M |
|
62
KALA BIO
KALA
$99.8M
| $25.9M | 0.51% |
69,069
| – | – |
|
63
Vulcan Materials
VMC
$38.3B
| $25.3M | 0.5% |
187,000
-211,400
| -53% | -$28.7M |
|
|
TECX
64
Tectonic Therapeutic, Inc. Common Stock
TECX
$338M
| $24.8M | 0.49% |
158,776
| – | – |
|
65
Cognex
CGNX
$7.4B
| $23.4M | 0.46% |
359,000
| – | – |
|
66
Okta
OKTA
$16B
| $23.1M | 0.45% |
108,000
| – | – |
|
67
Skyworks Solutions
SWKS
$10.9B
| $23M | 0.45% |
157,977
+9,777
| +7% | +$1.42M |
|
|
SMAR
68
DELISTED
Smartsheet Inc.
SMAR
| $21.6M | 0.42% |
437,000
-676,000
| -61% | -$33.4M |
|
69
KalVista Pharmaceuticals
KALV
$754M
| $21.2M | 0.41% |
1,680,000
| – | – |
|
70
Crinetics Pharmaceuticals
CRNX
$3.17B
| $21.1M | 0.41% |
1,347,000
| – | – |
|
|
AY
71
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $21.1M | 0.41% |
736,000
| – | – |
|
72
MongoDB
MDB
$25.8B
| $20.3M | 0.4% |
87,797
+1,797
| +2% | +$416K |
|
|
SGEN
73
DELISTED
Seagen Inc. Common Stock
SGEN
| $20.1M | 0.39% |
102,500
| – | – |
|
74
Sutro Biopharma
STRO
$83.9M
| $20M | 0.39% |
1,985,975
| – | – |
|
75
Monolithic Power Systems
MPWR
$40.1B
| $19.8M | 0.39% |
+70,975
| New | +$19.8M |
|